Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Something is up, but not the PPS.
We are literally 10 weeks from 1YR past data lock. We have to get the data soon. WTF.
We are now 29 days away from 2020 PR stating the final, final, third party data was received. Official 1 yr mark has to be that day at the latest. Data coming in T-29 days.....IMO
Yes. Buyside volume this afternoon to hold above $1.40 would create more buying tomorrow, IMO, as more Technical indicators move into positive direction. Would open that run to $1.50+. It would be nice to think we are on the upswing for reasons other than TA though.
Definitely a trader trigger that is watched. I just hope bottom is really in and move up is intact.
LOL. I have never traded this stock for swings. Ever. Last sale I had to make was in April to pay some taxes.
I moved my buy up to $1.37 and still sitting there. Stupid to chase pennies, should have bought at ask of $1.32
Yes, I put a buy in at $1.31 and then it jumped back up. Of course I chased it and still haven't been filled at $1.33.
Another low volume morning, although the bid/ask volumes are higher. I'm a buyer at these levels, but after lunch...or maybe sooner if there is another attempt to knock it down.
13,000 annual GBM diagnoses in the US alone per year. At $150,000 (low) per treatment would be a $2 Billion market. Worldwide it is closer to $6Billion annually. Other (not all) solid tumor treatments add another $20 Billion in US alone, annually. We are fine. Just need topline.
Another lunchtime bear raid. TA from yesterday's close says we finish green today, above $1.40.
It makes sense for the curve to move in our favor after separating placebo given historical survival data. If this is even close, it's a homerun!
Interesting that the conversions have slowed, very little this month. August 15th 10Q should give some insight to what has been issued/converted. Hopefully topline prior to that though...
Agreed, except this company will not exist 2yrs from now, IMO. Sold upon positive data and FDA approval submission. They clearly have no experience or resources to help patients after topline. It would be ego only to go it alone....at the expense of dying patients. The fastest way to help people is to get this to market asap via BP.
LOL, saw that. Quick move over $1.40 then back. Need volume to push through.
Today will be telling, IMO. Technical Reversal? Traders playing for a scalp? Run-up prior to PR? Who knows. I do believe we will see higher volume and choppy trading today, just a gut feeling from what the chart looks like.
Yes it was. $1.40 was a strong support for a while so likely will be strong resistance. Any move up tomorrow would be confirmation to me and reestablish support at $1.40. This has also been the longest negative bias on the ultimate oscillator in over a year, so a change in that trend would be reassuring as well. Baby Steps until news.
Interesting action in a very down market day. Would love to see a green close with Dow off 800!
Would love to see some solid afternoon buying to confirm bottom is in and get far enough above this support to signal a turn back upwards.
Looks like it. Unfortunately, $1.25 is the last support above $1.00. We could see a bear raid at this point. If it holds, we could see the bounce later today. Hoping others see a buying opportunity here like I do.
We are coming up against the one year mark from official trial completion. Without request for extension for a valid reason, NWBO HAS to release the data. I believe they have it ready to go and are waiting for peer review to be completed. They will wait as long as possible to have TLD and Journal as close together as possible. But, they are up against the 1yr mark of trial end.
Official Trial Completion Date: (per August 19th, 2020 PR) Probably happened a few days prior to PR.
"...today announced that the remaining outstanding clinical trial data for the Company’s Phase 3 trial of DCVax®-L for Glioblastoma brain cancer as described in the Company’s last report on July 24, 2020 has now been completed by the specialty analytics firms. With this data now in hand, final quality control checking and confirmation are under way to enable Data Lock."
We are one month away (worst case), IMO, from topline. Yes, they could ask for extension due to covid, etc., but that would have to be disclosed. Peer-review has likely been ongoing and no Journal can prevent NWBO from adhering to FDA or SEC rules for disclosure of data or material events. We also have a 10Q due by August 15th. I am hoping there is no vague language hinting at extension of time for data release.
279 days from data lock.....approaching the "average" 300 days for topline. Falls right in line with trial completion. August 11th says my magic 8 ball.
Per August 19th, 2020 PR on last data gathered for trial completion. Likely a few days prior to that. So, we are a month away at worst for topline without request for extension. We are also due for a 10Q by August 15th. Sawston submission for certification also could fall in that time frame next month. A lot should be coming. If not, I agree, we tank.
Certainly looks like it. However, All longs now the topline results HAVE to come out prior to the 1 yr trial completion date, which is likely only 3-4 weeks away. If you were in this long, why sell now?
This is the longest negative bias on the stock since the drop from $2.50 back to $1.20. And yet, we are nine months farther down the road towards topline. I can't wrap my head around the selling. Are there really that many traders in this stock? The low volume and lack of buying interest is killing the PPS. Awful.
Waiting to get published? Meaning, paper is done and being shopped? Or, it’s done, accepted by a journal and being reviewed? Either would imply we are in step six of plan.
What I don’t like is the paitience comment. It’s been over nine months! What do you call that! Let’s go already.
Maybe, but I would take it!!
Day traders and MM movement testing chart averages. They will continue to control the price until news. It is what it is unfortunately. We are maybe three weeks from: 1yr trial completion, 10 months from data lock. 5 weeks from 10Q and must be close on Sawston certification in that window as well. Should be a flurry of info coming in a couple weeks. Just surprised there isn't "leak" buying by now....unless it is "leak" selling....
Agreed. The last few days would normally have me expecting an 8K and financing. However, doubtful they could be issuing shares in the quiet period with material info under wraps. And, my chart yesterday looked like the 200DMA was going to be tested. If it holds, we should see a bounce. Unfortunately, news will be the only real mover of this stock...way up or way down. I believe way up and still sticking to my mid-August topline prediction.
Who is this guy? Looks like he is 12. And, he is wrong in his article:
The science and therapies are not similar. And,
"The company did eventually perform the interim analyses in 2017 and 2018, but released the results unblinded." --It was still blinded and blended data.
What a joke.
I'm still in the mid-August topline release camp. I believe we start seeing a move back up and higher volume. If so, it would be confirmation to me that we are getting close. 1 year from Official trial completion date is likely around a month away.
I believe we start to see the move up next week. FOMO will start to take over through July.
9 Months and plenty of time for analysis, review, article and peer-review. We are going to be up against the 1 yr mark of trial completion sometime between July 24th Plus two weeks.....Hopefully they won't have to take all that time and release on GBM day July 21st! Journal following right after. But, knowing LP, we could be middle of August, but that would be my latest expectation.
Monday will be 9 months from data lock PR. End of July/early August will be 1 yr from official trial completion. I am looking for a steady rise starting next week into the middle of the month as anticipation builds.
So, you are saying CVM released results a month and a half past their one year completion date? If so, that tells me we would see ours by end is September at latest as completion was sometime between July and August PR’s last year.
It's not me. I am always puzzled at the selling. If you even know about this stock you are in for the results. If there are scalpers risking being on the wrong side of topline, I would be surprised. There are a lot of easier targets. MM manipulation I get, but the biggest issue is not enough buying due to the silence, IMO.
Here comes the early lunchtime take down.
Like I said, $1.50 is the new $1.80 until news. Yes we got hit due to CVM but they locked after us and disclosed before us. You can say we have better data and we are waiting for a Journal, bla, bla, bla. The bottom line is we have no idea when any of that will happen. One year disclosure rule, blurred by covid delays and zero news from the company. That's why we sit here.